Coformulated N-Octanoyl-glucosylceramide Improves Cellular Delivery and Cytotoxicity of Liposomal DoxorubicinRobert Jan Veldman, Wim J. van Blitterswijk, Gerben A. Koning et al.|Journal of Pharmacology and Experimental Therapeutics|2005Cited by 33
Defined lipid analogues induce transient channels to facilitate drug-membrane traversal and circumvent cancer therapy resistanceAlbert J. van Hell, Marcel Verheij, Wim J. van Blitterswijk et al.|Scientific Reports|2013Cited by 24
Improving Intracellular Doxorubicin Delivery Through Nanoliposomes Equipped with Selective Tumor Cell Membrane Permeabilizing Short-Chain SphingolipidsLília R. Cordeiro Pedrosa, Gerben A. Koning, Albert J. van Hell et al.|Pharmaceutical Research|2013Cited by 19
Short-Chain Glycoceramides Promote Intracellular Mitoxantrone Delivery from Novel Nanoliposomes into Breast Cancer CellsLília R. Cordeiro Pedrosa, Gerben A. Koning, Timo L.M. ten Hagen et al.|Pharmaceutical Research|2014Cited by 16
Membrane organization determines barrier properties of endothelial cells and short-chain sphingolipid-facilitated doxorubicin influxAlbert J. van Hell, Marcel Verheij, Andrey S. Klymchenko et al.|Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids|2014Cited by 5